PATENT PROTECTED HYDROGEL
Our platform technology consists of mainly two materials which have the following properties:
Inverse Thermal Gelling
Our hydrogel provides a sustained therapeutic release which out-competes other available technologies.
AmacaThera is a Toronto-based biotechnology company focused on developing and commercializing a unique, injectable hydrogel platform technology for a wide range of medical applications.
Based on the research of world-renowned biomaterials scientist, Dr. Molly Shoichet, AmacaThera is commercializing combination products at the interface of biomaterials and pharmaceuticals.
We have developed a platform technology which addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas.
Currently, we have developed a combination product for post-operative pain, which is our company's lead project.